Regencell Bioscience Quote - RGC

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

29.12

Bid

27.50

Ask

29.80

Volume

18,751

27.0482 Day's Range 29.4994

3.00 52 Week Range 69.00

Market Cap

378.935M

Previous Close

27.25

Open

27.95

Last Trade

29.56

Last Trade Time

Financial Volume

US$ 530,533

VWAP

28.2936

Average Volume (3m)

716,450

Shares Outstanding

13,012,866

Dividend Yield

PE Ratio

-87.72

Earnings Per Share (EPS)

-0.33

Revenue

Net Profit

-4.3M

Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration. Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.

Sector

Medicinal Chems,botanicl Pds

Industry

Medicinal Chems,botanicl Pds

Website

www.regencellbioscience.com

Headquarters

Hong Kong, Hkg

Founded

Regencell Bioscience Holdings Ltd is listed in the Medicinal Chems,botanicl Pds sector of the NASDAQ with ticker RGC. The last closing price for Regencell Bioscience was US$27.25. Over the last year, Regencell Bioscience shares have traded in a share price range of US$ 3.00 to US$ 69.00.

Regencell Bioscience currently has 13,012,866 shares outstanding. The market capitalization of Regencell Bioscience is US$354.60 million. Regencell Bioscience has a price to earnings ratio (PE ratio) of -87.72.

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Regencell Bioscience’s Standardized Formulae Are Shown to Reduce ADHD and ASD Symptoms in the Interim Results of its Second Efficacy Trial

- The Sik-Kee Au TCM Brain Theory® Assessment for ADHD and ASD (“SKATBT-A3”), which measures the effectiveness of the treatment on the patient’s...

Game-Stop Or Game-On? RGC Has It All And Twice More

Shorted with over 19 million shares and almost 2x the ratio compared to GameStop (NYSE:GME), RGC is still trading 150% above IPO price. While its...

Regencell Bioscience Announces Additional EARTH Efficacy Trial Results Corroborating Effectiveness of its Investigational Liquid-Formula RGC-COV19TM in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-Day Treatment Period

Regencell Bioscience Holdings Limited (NASDAQ: RGC): Results of EARTH efficacy trial EARTH Efficacy Trials Period of trial 30 January 2022...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.01	0.0343524562006	29.11	41.16	25.29	70702	34.05484333	CS
4	-0.8	-2.67379679144	29.92	69	21.0001	272532	41.64066276	CS
12	24.37	513.052631579	4.75	69	3.526	716450	19.32139053	CS
26	24.33	507.933194154	4.79	69	3.526	382929	17.69309459	CS
52	25.74	761.538461538	3.38	69	3	244695	16.21922768	CS
156	7.08	32.1234119782	22.04	69	3	83435	16.49494232	CS
260	17.12	142.666666667	12	69	3	125292	23.68929128	CS

RGC - Frequently Asked Questions (FAQ)

What is the current Regencell Bioscience share price?

The current share price of Regencell Bioscience is US$ 29.12

How many Regencell Bioscience shares are in issue?

Regencell Bioscience has 13,012,866 shares in issue

What is the market cap of Regencell Bioscience?

The market capitalisation of Regencell Bioscience is USD 354.6M

What is the 1 year trading range for Regencell Bioscience share price?

Regencell Bioscience has traded in the range of US$ 3.00 to US$ 69.00 during the past year

What is the PE ratio of Regencell Bioscience?

The price to earnings ratio of Regencell Bioscience is -87.72

What is the reporting currency for Regencell Bioscience?

Regencell Bioscience reports financial results in USD

What is the latest annual profit for Regencell Bioscience?

The latest annual profit of Regencell Bioscience is USD -4.3M

What is the registered address of Regencell Bioscience?

The registered address for Regencell Bioscience is 11/F FIRST COMMERCIAL BUILDING, 33-35 LEIGHTON ROAD, HONG KONG, 999077

What is the Regencell Bioscience website address?

The website address for Regencell Bioscience is www.regencellbioscience.com

Which industry sector does Regencell Bioscience operate in?

Regencell Bioscience operates in the MEDICINAL CHEMS,BOTANICL PDS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MSGMMotorsport Games Inc	US$ 2.69 (140.18%)	37M
SXTCChina SXT Pharmaceuticals Inc	US$ 2.11 (113.37%)	51.73M
ADGMAdagio Medical Holdings Inc	US$ 1.68 (81.98%)	115.48M
PNBKPatriot National Bancorp Inc	US$ 3.28 (73.54%)	1.57M
RTCBaijiayun Group Ltd	US$ 0.3601 (67.49%)	187.02M
LXEHLixiang Education Holding Company Ltd	US$ 8.25 (-64.11%)	1.55M
CLIKClick Holdings Ltd	US$ 0.355 (-48.18%)	13.52M
IOTRiOThree Ltd	US$ 1.1409 (-38.33%)	3.93M
FMTOFemto Technologies Inc	US$ 0.0191 (-35.47%)	198.4M
SISIShineco Inc	US$ 0.5809 (-35.07%)	824.91k
DMNDamon Inc	US$ 0.0034 (9.68%)	409.39M
STSSSharps Technology Inc	US$ 0.03195 (20.57%)	391.8M
SUNESUNation Energy Inc	US$ 0.0176 (-10.20%)	349.4M
NVDANVIDIA Corporation	US$ 101.49 (-2.87%)	292.48M
HTZHertz Global Holdings Inc	US$ 8.205 (43.70%)	266.91M